{
    "N/R/U": null,
    "Applicant": "Merck Sharp & Dohme LLC",
    "BLA Number": "103552",
    "Proprietary Name": "Varivax",
    "Proper Name": "Varicella Virus Vaccine Live",
    "BLA Type": "351(a)",
    "Strength": "NLT  1350PFU/.5ML",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "February 27, 2023",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "6277",
    "Submission Type": "Supplement",
    "License Number": "0002",
    "Product Number": "002",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}